GLS and autoimmune disease: In autoimmune diseases, dysregulated expression of the glutaminase enzyme GLS1 drives increased acetyl-CoA production, leading to enhanced histone acetylation at the Il17a promoter, thereby promoting Th17 and γδT17 cell differentiation [94].